Homoharringtonine induced immune alteration for an Efficient Anti-tumor Response in Mouse Models of Non-small Cell Lung Adenocarcinoma Expressing Kras Mutation

Homoharringtonine (HHT), an inhibitor of protein synthesis, has been used to treat leukemia. Its therapeutic effects on non-small cell lung adenocarcinoma carrying KRAS mutation and their immune system are less understood. The present study examined the therapeutic efficacy and the immune effects of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Weng, Tzu-Yang, Wu, Hsuan Franziska, Li, Chung-Yen, Hung, Yu-Hsuan, Chang, Yu-Wei, Chen, Yi-Ling, Hsu, Hui-Ping, Chen, Yu-Hung, Wang, Chih-Yang, Chang, Jang-Yang, Lai, Ming-Derg
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5974086/
https://ncbi.nlm.nih.gov/pubmed/29844447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-26454-w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados